Literature DB >> 21398249

Recent massive blood transfusion practice in England and Wales: view from a trauma registry.

Gordon Fuller1, Omar Bouamra, Maralyn Woodford, Tom Jenks, Simon Stanworth, Shubha Allard, Timothy J Coats, Karim Brohi, Fiona Lecky.   

Abstract

BACKGROUND: Few studies have characterised massive blood transfusion (MBT) practice in UK trauma. This study describes the Trauma Audit and Research Network experience of MBT over a 4-year period, and examines variables predictive of MBT and mortality following MBT.
METHODS: Prospectively collected data between 2005 and 2009 from the Trauma Audit and Research Network database were analysed. MBT incidence was examined, and patient characteristics, blood component usage and mortality compared to non-MBT patients. Clinical and injury features predictive of massive transfusion, and risk factors predictive of death in MBT, were analysed using multivariate logistic regression.
RESULTS: 157 patients (0.4%) received MBT, with a mortality rate of 40.3%. MBT patients were younger, more likely to be male and to have sustained more severe trauma (median age 39.2 years, median Injury Severity Score 27, 78% male, p<0.01). No patients received platelets and fresh frozen plasma (FFP) in 1:1 ratios with packed red cells. Multivariate analysis showed: age, admission pulse rate, systolic blood pressure, and injury type; thoracic, abdominal, pelvis, were significant predictors of MBT. Injury Severity Score and admission pulse rate were also independent predictors of death in MBT, but level of platelet and FFP use were not found to be statistically significant.
CONCLUSION: MBT is a rare event with high mortality in UK trauma. Haemostatic resuscitation is not currently practiced in the UK and the authors were unable to show that FFP and platelet use were significant predictors of survival in MBT.

Entities:  

Mesh:

Year:  2011        PMID: 21398249     DOI: 10.1136/emj.2010.104349

Source DB:  PubMed          Journal:  Emerg Med J        ISSN: 1472-0205            Impact factor:   2.740


  5 in total

Review 1.  The Diagnosis and Treatment of Acute Traumatic Bleeding and Coagulopathy.

Authors:  Marc Maegele
Journal:  Dtsch Arztebl Int       Date:  2019-11-22       Impact factor: 5.594

2.  Benchmarking of trauma care worldwide: the potential value of an International Trauma Data Bank (ITDB).

Authors:  Adil H Haider; Zain G Hashmi; Sonia Gupta; Syed Nabeel Zafar; Jean-Stephane David; David T Efron; Kent A Stevens; Hasnain Zafar; Eric B Schneider; Eric Voiglio; Raul Coimbra; Elliott R Haut
Journal:  World J Surg       Date:  2014-08       Impact factor: 3.352

3.  Quantifying the healthcare costs of treating severely bleeding major trauma patients: a national study for England.

Authors:  Helen E Campbell; Elizabeth A Stokes; Danielle N Bargo; Nicola Curry; Fiona E Lecky; Antoinette Edwards; Maralyn Woodford; Frances Seeney; Simon Eaglestone; Karim Brohi; Alastair M Gray; Simon J Stanworth
Journal:  Crit Care       Date:  2015-07-06       Impact factor: 9.097

4.  The European Perspective on the Management of Acute Major Hemorrhage and Coagulopathy after Trauma: Summary of the 2019 Updated European Guideline.

Authors:  Marc Maegele
Journal:  J Clin Med       Date:  2021-01-19       Impact factor: 4.241

5.  Red blood cell transfusion and mortality in trauma patients: risk-stratified analysis of an observational study.

Authors:  Pablo Perel; Tim Clayton; Doug G Altman; Peter Croft; Ian Douglas; Harry Hemingway; Aroon Hingorani; Katherine I Morley; Richard Riley; Adam Timmis; Danielle Van der Windt; Ian Roberts
Journal:  PLoS Med       Date:  2014-06-17       Impact factor: 11.069

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.